BBlogFlow

AI hacks into Australia's health database: Dr. Peter Lin explains - CBC

·Oct 1, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Why screen time should be treated as a public health issue: Dr. Peter Lin explains - CBC

Skip to Main ContentAccessibility HelpMenuCBC GemCBC ListenSearchQuick LinksNewsSportsRadioMusicListen LiveTVWatchradioTop StoriesShowsPodcastsSchedulesFrequencyListen LiveVideoWhy screen time should be treated as a public health issue: Dr. Peter Lin explains | CBC.ca LoadedThe Morning Edition - K-W7:49Why screen time should be treated as a public health issue: Dr. Peter Lin explainsOctober 8RadioDuration 7:49Dopamine on demand. Dr. Peter Lin explains how tech companies exploit our brain chemistry, and discusses a new study that calls for government action. More from RadioVideoDuration 1:18‘She’s trying to change the culture of Cornell,’ says Jane Doe’s lawyerOctober 14VideoDuration 1:04Jane Doe’s home was swatted, says lawyer in Cornell gang-rape caseOctober 14VideoDuration 1:40How menopause shook Olympian Clara HughesOctober 12VideoDuration 1:53Will Carney's plan to 'Build Canada Strong' hurt the environment?

CBC·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·